HCV Reinfection Rare Among Patients Receiving Opioid Agonist Therapy - Contagionlive.com

Rates of hepatitis C reinfection were low among people receiving opioid agonist therapy, according to a new study, which highlights the importance of risk reduction interventions and HCV treatment for people who inject drugs and people receiving opioid agonis…

After successful antiviral treatment of hepatitis C infection, the risk of reinfection was low among patients receiving opioid agonist therapy, a recent study found. The study, published in Annals o… [+3558 chars]

full article...